Platelet Pathogen Reduction Technology Implementation at Stanford Blood Center
Runtime: ~25 minutes
Part 2 of 3 – AABB Science and Innovation Forum: Mitigating Bacterial Risk in Platelets: Blood Center and Transfusion Services Perspectives from University of Utah & Stanford
Learn about optimizing your blood center’s pathogen reduced platelet inventory.
In this webinar Stanford Blood Center presents its approach to mitigating bacterial risk in platelets with pathogen reduction. Current and planned production optimization measures, including variable dose platelets, are discussed to achieve a 100% pathogen-reduced platelet inventory.
Tho D. Pham, MD
Clinical Associate Professor, Department of Pathology, Stanford University
Chief Medical Officer, Stanford Blood Center
Dr. Pham has been faculty in the Department of Pathology at Stanford since 2014. His clinical research interest involves developing statistical and programmatic approaches to improve blood product availability and to improve overall health care efficiency. Dr. Pham’s scientific research interests include studying antibody function as it relates to transfusion medicine, blood safety, and emerging infectious diseases.